Douglas P Golwas sold $3.7M of MDLN
Chief Commercial Officer at Medline Inc.. 100,000 shares at an average of $36.77, traded Jun 16, 2026, filed Jun 17, 2026.
Score components
- +15RoleOfficer
- +25Trade size$3.7M at market
- +20Share of holdings soldSold 81% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-274287, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | FTax withholding Class A Common Stock10b5-1 | -1,889 | $36.61 | $69k | 23,899 | Jun 17, 2026 |
| Jun 16, 2026 | MOption exercise Class A Common Stock10b5-1 | +100,000 | - | - | 123,899 | Jun 17, 2026 |
| Jun 16, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -61,966 | $36.60 | $2.3M | 61,933 | Jun 17, 2026 |
| Jun 16, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -38,034 | $37.05 | $1.4M | 23,899 | Jun 17, 2026 |
| Jun 16, 2026 | DDisposition to issuer Class B Common Stock10b5-1 | -100,000 | - | - | 365,864 | Jun 17, 2026 |
| Jun 16, 2026 | MOption exercise Common Units of Medline Holdings, LPderivativeindirect: See Footnote10b5-1 | -100,000 | $0.00 | $0 | 365,864 | Jun 17, 2026 |
Related signals
Other insiders at Medline Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | MDLNsell Medline Inc. | GIC Private Ltd owner | $722M 20,678,630 shares | -91% | |
| 37Weak | MDLNsell Medline Inc. | GIC Private Ltd owner | $57M 1,600,000 shares | -7% | |
| 37Weak | MDLNsell Medline Inc. | GIC Private Ltd owner | $21M 590,284 shares | -2% | |
| 37Weak | MDLNsell Medline Inc. | GIC Private Ltd owner | $80M 2,248,612 shares | -8% | |
| 52Moderate | MDLNbuy Medline Inc. | Jessi L Corcoran Principal Accounting Officer | $171k 5,000 shares | - | |
| 62Notable | Medline Inc. | BCP 8 Holdings Mozart Manager L.L.C. owner | $1.2B 33,317,824 shares | -30% | |
| 62Notable | Medline Inc. | BX Mozart ML-2 Holdco L.P. owner | $1.2B 33,317,824 shares | -30% | |
| 72Notable | Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. owner | $1.2B 31,868,237 shares | -175% | |
| 57Moderate | Medline Inc. | BCP 8 Holdings Mozart Manager L.L.C. owner | $1.1B 27,852,986 shares | -22% | |
| 57Moderate | Medline Inc. | BX Mozart ML-2 Holdco L.P. owner | $1.1B 27,852,986 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.